News & Updates
Filter by Specialty:
Single-dose baloxavir reduces household transmission of influenza
A single dose of baloxavir given to an index patient (IP) reduces the odds of influenza transmission to untreated household contacts (HHCs) by 32 percent vs placebo, according to the results of the phase IIIb CENTERSTONE trial.
Single-dose baloxavir reduces household transmission of influenza
30 Apr 2025
Oral microbiota may identify autism in kids with >80 percent accuracy
Eleven oral bacterial species may serve as biomarkers for early detection of autism through simple oral sampling, with an accuracy of 81 percent, according to a cross-disciplinary research team from the Faculty of Dentistry and the Department of Psychology of the University of Hong Kong (HKU).
Oral microbiota may identify autism in kids with >80 percent accuracy
29 Apr 2025
SOF/VEL combo improves well-being of children with CHC
In children with chronic hepatitis C (CHC), effective treatment with sofosbuvir/velpatasvir (SOF/VEL) results in improvements in certain areas of their well-being at 1 year. This suggests some patient-reported outcomes (PRO) benefits of direct-acting antiviral (DAA) therapy. However, the parents’ proxy reports show a decrease in the patients’ school functioning.
